Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm treats first subjects in phase 3 trial of zilosul

Jan 13, 2022 at 2:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment